A single-arm, open-label phase 2 trial of doxorubicin plus zalifrelimab, a CTLA-4 inhibitor, with balstilimab, a PD-1 inhibitor, in patients with advanced/metastatic soft tissue sarcomas

被引：0
|
作者：
Wilky, Breelyn A.
Maleddu, Alessandra
Mailhot, Anne
Cartwright, Chelsey
Gao, Dexiang
Tellez, Cristiam Moreno
Powers, Kyle
Kemp, Lindsey
Therrien, Nicholas
Patel, Jaymin M.
Grossman, Joseph Elan
O'Day, Steven
Elias, Anthony D.
机构：
[1] Univ Colorado Anschutz Med Campus, Aurora, CO USA
[2] Univ Colorado, Sch Med, Aurora, CO USA
[3] Univ Colorado, Canc Ctr, Aurora, CO USA
[4] Univ Colorado, Aurora, CO USA
[5] Univ Colorado Anschutz Med Campus, Denver, CO USA
[6] Agenus Inc, Boston, MA USA
[7] Agenus Inc, Lexington, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
11501
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Camrelizumab plus apatinib in patients with advanced cervical cancer: A multicenter, open-label, single-arm, phase II trial.
    Lan, Chunyan
    Huang, Xin
    Shen, Jing-Xian
    Wang, Yin
    Xiong, Ying
    Li, Jundong
    Cao, Xinping
    Deng, Yanhong
    He, Mian
    Zou, Guorong
    Wang, Xiaodi
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [32] A PHASE 1B OPEN-LABEL, SINGLE-ARM DOSE EXPANSION STUDY OF IK-175, AN ORAL AHR INHIBITOR, IN COMBINATION WITH NIVOLUMAB IN PATIENTS WITH PRIMARY PD-1 INHIBITOR RESISTANT ADVANCED HEAD AND NECK CANCER
    Lingaraj, Trupti
    Timothy, Marissa
    Ortiz-Otero, Nerymar
    Bartolini, Wilmin
    Kacena, Katherine
    Malek, Karim
    Santillana, Sergio
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A710 - A710
  • [33] An Open-label, Single-arm, Phase 2 Trial of Panitumumab Plus FOLFIRI as Second-line Therapy in Patients with Metastatic Colorectal Cancer
    Cohn, Allen L.
    Shumaker, Grace C.
    Khandelwal, Pankaj
    Smith, David A.
    Neubauer, Marcus A.
    Mehta, Nilesh
    Richards, Donald
    Watkins, David L.
    Zhang, Kathy
    Yassine, Mohamed R.
    CLINICAL COLORECTAL CANCER, 2011, 10 (03) : 171 - 177
  • [34] Erdafitinib in Asian patients with advanced solid tumors: an open-label, single-arm, phase IIa trial
    Park, Joon Oh
    Feng, Yin-Hsun
    Su, Wu-Chou
    Oh, Do-Youn
    Keam, Bhumsuk
    Shen, Lin
    Kim, Sang-We
    Liu, Xiufeng
    Liao, Huimin
    Qing, Min
    Zhang, Chong
    Qian, Jiaqi
    Tang, Xiaodan
    Li, Peng
    Triantos, Spyros
    Sweiti, Hussein
    BMC CANCER, 2024, 24 (01)
  • [35] Randomized phase II trial of cabozantinib combined with PD-1 and CTLA-4 inhibition versus cabozantinib in metastatic soft tissue sarcoma
    Van Tine, Brian Andrew
    Eulo, Vanessa
    Toeniskoetter, Jacqui
    Ruff, Tyler
    Luo, Jingqin
    Kemp, Lindsey
    Tellez, Cristiam Moreno
    Weiss, Mia C.
    Hirbe, Angela C.
    Meyer, Christian Frederick
    Elias, Anthony D.
    Diamond, Mark
    Hartner, Lee P.
    Bui, Nam
    Ganjoo, Kristen N.
    Maki, Robert G.
    Wilky, Breelyn A.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (17)
  • [36] Tucidinostat plus toripalimab in patients with unresectable or metastatic melanoma: An open-label, single-arm phase II study
    Mao, Lili
    Dai, Jie
    Bai, Xue
    Kong, Yan
    Sheng, Xinan
    Chi, Zhihong
    Cui, Chuanliang
    Lian, Bin
    Tang, Bixia
    Yan, Xieqiao
    Wang, Xuan
    Li, Siming
    Zhou, Li
    Wei, Xiaoting
    Li, Juan
    Li, Caili
    Duan, Rong
    Xu, Huayan
    Guo, Jun
    Si, Lu
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [37] A single-arm, multicenter, open-label phase 2 trial of surufatinib in patients with unresectable or metastatic biliary tract cancer
    Xu, Jianming
    Bai, Yuxian
    Sun, Huichuan
    Bai, Chunmei
    Jia, Ru
    Li, Yi
    Zhang, Wenjie
    Liu, Lei
    Huang, Cheng
    Guan, Mei
    Zhou, Jinghong
    Su, Weiguo
    CANCER, 2021, 127 (21) : 3975 - 3984
  • [38] Phase 1, single-arm, open-label, dose escalation trial of microneedle array-doxorubicin in patients with mycosis fungoides
    Akilov, O. E.
    McCann, S.
    Chao, E. D.
    Cullison, S. Jackson
    Erdos, G.
    Falo, L. D., Jr.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2018, 138 (05) : S99 - S99
  • [39] Phase 1, single-arm, open-label, dose escalation trial of microneedle array-doxorubicin in patients with mycosis fungoides
    Akilov, Oleg
    McCann, Sue
    Erdos, Geza
    Falo, Louis D.
    EUROPEAN JOURNAL OF CANCER, 2018, 101 : S32 - S32
  • [40] Camrelizumab Plus Apatinib in Treatment-Naive Patients With Advanced Nonsquamous NSCLC: A Multicenter, Open-Label, Single-Arm, Phase 2 Trial
    Ren, Shengxiang
    He, Jianxing
    Fang, Yong
    Chen, Gongyan
    Ma, Zhiyong
    Chen, Jianhua
    Guo, Renhua
    Lin, Xiaoyan
    Yao, Yu
    Wu, Gang
    Wang, Quanren
    Zhou, Caicun
    JTO CLINICAL AND RESEARCH REPORTS, 2022, 3 (05):
12345